Status:
COMPLETED
Oxygen Saturation and Perfusion Index ın Neonates at High Altitude
Lead Sponsor:
Ataturk University
Conditions:
Critical Congenital Heart Disease
High Altitude
Eligibility:
All Genders
24-48 years
Brief Summary
Congenital heart diseases are among the most common congenital anomalies and occur with an incidence of approximately 8ınd12 / 1,000 live births worldwide. This figure does not cover minor lesions suc...
Eligibility Criteria
Inclusion
- The newborns delivered in Ataturk University Hospital and ≥34 weeks of gestational age were eligible for the study.
Exclusion
- Outborn and premature babies (\<34 weeks) were not included. Babies with a prenatal diagnosis of congenital heart disease were excluded.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
501 Patients enrolled
Trial Details
Trial ID
NCT04290481
Start Date
June 1 2018
End Date
February 1 2019
Last Update
March 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ataturk University Medical Faculty
Erzurum, Turkey (Türkiye), 25100